Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibogaine for cocaine and crack dependence
RBR-4bmwsdzPhase 3Not yet recruiting
- Sponsor
- VeraCruz Brasil
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibogaine in cocaine use disorder (CUD) and substance use disorder (SUD) (8 arms), sponsored by VeraCruz Brasil. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ibogaine
03
Conditions
cocaine use disorder (CUD)substance use disorder (SUD)
Beyond the preview
Go deeper on RBR-4bmwsdz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4bmwsdz.